HALO
#797
Halozyme Therapeutics, Inc. - Common Stock
109.4 9 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.15%
Changement Mensuel
+30.50%
Evolution sur 6 mois
+58.41%
Changement Annuel
+63.91%
Clôture Précédente
110.7 6
Open
109.9 1
Low
109.3 5
High
111.1 5
Volume
372
Financials
- Market Capitalization 12.43 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
22.89
ratio cours/chiffre d'affaires
5.77
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 751 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.12 USD | -0.06% | +23.88% | +23.08% | -13.80% | 13.66 B USD | ||
| 782 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.72 USD | -1.07% | +1.75% | +6.93% | +16.03% | 12.72 B USD | ||
| 801 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 539.35 USD | -0.60% | +0.04% | +5.57% | +27.32% | 12.46 B USD | ||
| 813 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.63 USD | -0.99% | -0.83% | -2.13% | +119.00% | 12.10 B USD |